Holen Sie sich die Stockscreener-App
92.23
4.40%
-4.24
Handel nachbörslich:
92.23
Schlusskurs vom Vortag:
$96.47
Offen:
$96.34
24-Stunden-Volumen:
447.68K
Relative Volume:
0.30
Marktkapitalisierung:
$2.68B
Einnahmen:
$861.31M
Nettoeinkommen (Verlust:
$53.12M
KGV:
53.43
EPS:
1.7262
Netto-Cashflow:
$85.01M
1W Leistung:
-6.25%
1M Leistung:
-20.15%
6M Leistung:
-27.66%
1J Leistung:
-46.94%
1-Tages-Spanne:
$91.90
$96.82
1-Wochen-Bereich:
$91.11
$98.50
52-Wochen-Spanne:
$70.77
$203.12
Inspire Medical Systems Inc Stock (INSP) Company Profile
Firmenname
Inspire Medical Systems Inc
Sektor
Branche
Telefon
763-957-5037
Adresse
5500 WAYZATA BLVD, GOLDEN VALLEY
Vergleichen Sie INSP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
92.23 | 2.80B | 861.31M | 53.12M | 85.01M | 1.7262 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Hochstufung | Truist | Hold → Buy |
| 2025-11-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-11-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2025-09-02 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Herabstufung | Truist | Buy → Hold |
| 2024-11-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-04-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-03-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2024-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-12-13 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-11-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-11-03 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-15 | Eingeleitet | Goldman | Buy |
| 2020-06-18 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-18 | Eingeleitet | Lake Street | Buy |
| 2020-04-28 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-28 | Eingeleitet | Oppenheimer | Underperform |
| 2020-01-27 | Eingeleitet | Oppenheimer | Underperform |
| 2019-11-06 | Hochstufung | Berenberg | Sell → Hold |
| 2019-02-05 | Eingeleitet | Dougherty & Company | Buy |
| 2018-11-28 | Eingeleitet | Berenberg | Sell |
| 2018-10-29 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-29 | Eingeleitet | Guggenheim | Buy |
| 2018-05-29 | Eingeleitet | Stifel | Buy |
| 2018-05-29 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Inspire Medical Systems Inc Aktie (INSP) Neueste Nachrichten
Inspire Medical Systems, Inc. (INSP): A Bull Case Theory - Finviz
Swing Trade: What is JYNTs P E ratio telling usWeekly Stock Recap & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Wells Fargo Maintains Overweight Rating on INSP, Lowers Price Ta - GuruFocus
Will New CFO Hire And Inspire V Launch Plus 2026 Guidance Change Inspire Medical Systems' (INSP) Narrative? - Yahoo Finance
Insider Sell: John Rondoni Sells Shares of Inspire Medical Syste - GuruFocus
JPM26: Inspire Medical Systems projects a strong 2026 - Yahoo Finance
Inspire appoints Matt Osberg as CFO - MedTech Dive
Impulse Dynamics® Announces New Chief Financial Officer - The Manila Times
Inspire Medical Systems appoints Matt Osberg as new CFO By Investing.com - Investing.com Nigeria
Inspire Medical Systems (NYSE:INSP) Insider Sells $10,900.00 in Stock - MarketBeat
Inspire Medical Systems Issues Strong Preliminary 2025 Revenue Results - TipRanks
Jefferies raises Inspire Medical Systems stock price target to $100 on strong Q4 - Investing.com Canada
Inspire Medical Systems (NYSE: INSP) sets CFO transition, preliminary 2025 results - Stock Titan
INSP: Inspire V drives growth with improved outcomes, strong guidance, and ongoing innovation - TradingView — Track All Markets
INSP: Inspire 5's launch accelerates growth, innovation, and patient outcomes, with strong 2026 outlook - TradingView — Track All Markets
Inspire Medical names new CFO, reports preliminary Q4 results - MassDevice
Inspire Medical Systems announces Q4 and FY25 guidance, appoints new CFO - MSN
INSP Forecasts 10%-11% Growth by 2025 - GuruFocus
Inspire Medical Systems (INSP) Reports Strong Revenue Growth in 2025 - GuruFocus
INSP Appoints Matt Osberg as New Executive Vice President and CF - GuruFocus
Inspire Q4 Prel. Revenue Rises 12%, Sees Double-Digit Growth In 2026; Names Matt Osberg CFO - Nasdaq
Inspire Medical Systems appoints Matt Osberg as new CFO - Investing.com
Inspire Medical Systems Reports Preliminary Q4 2025 Results and Appoints New CFO - Quiver Quantitative
Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance - The Manila Times
Allspring Global Investments Holdings LLC Has $298,000 Stock Holdings in Inspire Medical Systems, Inc. $INSP - MarketBeat
Do Inspire Medical Systems’ (INSP) Lawsuits Hint at Deeper Questions About Execution and Transparency? - Sahm
Inspire Medical slides after Medicare reimbursement policy change - MSN
Why We're Not Concerned Yet About Inspire Medical Systems, Inc.'s (NYSE:INSP) 32% Share Price Plunge - simplywall.st
Will Inspire Medical Systems Inc. stock benefit from commodity prices2025 Price Targets & Long-Term Growth Stock Strategies - ulpravda.ru
Is Inspire Medical Systems Inc. stock overvalued by current metrics2025 Short Interest & Free Long-Term Investment Growth Plans - ulpravda.ru
Can Inspire Medical Systems Inc. stock sustain institutional interestGap Down & Weekly High Return Stock Opportunities - ulpravda.ru
How Inspire Medical Systems Inc. stock reacts to bond yieldsJuly 2025 WrapUp & AI Powered Market Entry Strategies - ulpravda.ru
A Look At Inspire Medical Systems (INSP) Valuation After Lawsuits Over Inspire V Launch Disclosures - Yahoo Finance
Inspire Medical Systems (NYSE:INSP) Stock Price Down 6.3%Here's Why - MarketBeat
Truist Securities Lowers Price Target for INSP to $120, Maintains 'Buy' Rating | INSP Stock News - GuruFocus
Truist Securities lowers Inspire Medical Systems stock price target to $120 - Investing.com Canada
Assessing Inspire Medical Systems (INSP) Valuation As Inspire V Lawsuits And Rollout Issues Weigh On Sentiment - Sahm
Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 - The Manila Times
2026 world cup world class players breakdown: Can Inspire Medical Systems Inc. stock sustain institutional interest2026 world cup usa national team third place match playmakers pressing system odds analysis breakdown - Улправда
Inspire Medical Systems (INSP) Hit by Execution Difficulties in Q3 - Finviz
January 5, 2026 Deadline Approaching: Join Class Action Against Inspire Medical Systems, Inc. (INSP)Contact Levi & Korsinsky - ACCESS Newswire
Class Action Filed Against Inspire Medical Systems, Inc. (INSP) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Recover Investment Losses: Class Action Initiated Against Inspire Medical Systems, Inc. (INSP) - ACCESS Newswire
Inspire Medical Systems, Inc. (NYSE: INSP) Investor Alert: Deadline in Lawsuit on January 5, 2026 - openPR.com
Lost Money on Inspire Medical Systems, Inc. (INSP)? Join Class Action Before January 5, 2026Contact Levi & Korsinsky - ACCESS Newswire
2026-01-05 | Class Action Filed Against Inspire Medical Systems, Inc. (INSP) Over Securities ViolationsContact Levi & Korsinsky Today | NYSE:INSP | Press Release - Stockhouse
FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Reminds Inspire Medical Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026 - The AI Journal
Bronstein, Gewirtz & Grossman LLC Urges Inspire Medical - GlobeNewswire
INSPIRE MEDICAL FINAL DEADLINE ALERT: Bragar Eagel & - GlobeNewswire
The Gross Law Firm Reminds Inspire Medical Systems, Inc. Investo - GuruFocus
INSP Investors Have Opportunity to Lead Inspire Medical - GlobeNewswire
Finanzdaten der Inspire Medical Systems Inc-Aktie (INSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
1.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):